207 related articles for article (PubMed ID: 25259581)
1. Non-contrast-enhanced whole-body magnetic resonance imaging in the general population: the incidence of abnormal findings in patients 50 years old and younger compared to older subjects.
Cieszanowski A; Maj E; Kulisiewicz P; Grudzinski IP; Jakoniuk-Glodala K; Chlipala-Nitek I; Kaczynski B; Rowinski O
PLoS One; 2014; 9(9):e107840. PubMed ID: 25259581
[TBL] [Abstract][Full Text] [Related]
2. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study.
Schmidt GP; Wintersperger B; Graser A; Baur-Melnyk A; Reiser MF; Schoenberg SO
Invest Radiol; 2007 Jun; 42(6):449-59. PubMed ID: 17507818
[TBL] [Abstract][Full Text] [Related]
3. Whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in prostate cancer: Prevalence and clinical significance of incidental findings.
Kumasaka S; Motegi S; Kumasaka Y; Nishikata T; Otomo M; Tsushima Y
Br J Radiol; 2022 Mar; 95(1131):20210459. PubMed ID: 34111963
[TBL] [Abstract][Full Text] [Related]
4. MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT).
Frericks BB; Meyer BC; Martus P; Wendt M; Wolf KJ; Wacker F
J Magn Reson Imaging; 2008 Mar; 27(3):538-45. PubMed ID: 18224677
[TBL] [Abstract][Full Text] [Related]
5. Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence.
Costelloe CM; Madewell JE; Kundra V; Harrell RK; Bassett RL; Ma J
Magn Reson Imaging; 2013 Jun; 31(5):669-75. PubMed ID: 23290478
[TBL] [Abstract][Full Text] [Related]
6. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
7. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
[TBL] [Abstract][Full Text] [Related]
8. Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations.
Zugni F; Padhani AR; Koh DM; Summers PE; Bellomi M; Petralia G
Cancer Imaging; 2020 May; 20(1):34. PubMed ID: 32393345
[TBL] [Abstract][Full Text] [Related]
9. Whole-body MRI in patients with lymphoma: collateral findings.
Galia M; Albano D; Narese D; Patti C; Chianca V; Di Pietto F; Mulè A; Grassedonio E; La Grutta L; Lagalla R; Midiri M
Radiol Med; 2016 Oct; 121(10):793-800. PubMed ID: 27307001
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
Jacobs MA; Macura KJ; Zaheer A; Antonarakis ES; Stearns V; Wolff AC; Feiweier T; Kamel IR; Wahl RL; Pan L
Acad Radiol; 2018 Nov; 25(11):1405-1414. PubMed ID: 29627288
[TBL] [Abstract][Full Text] [Related]
11. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns.
Weininger M; Lauterbach B; Knop S; Pabst T; Kenn W; Hahn D; Beissert M
Eur J Radiol; 2009 Feb; 69(2):339-45. PubMed ID: 18096344
[TBL] [Abstract][Full Text] [Related]
12. Whole-body MRI for preventive health screening in a general population: Prevalence of incidental findings around the hip.
Na Kim J; Jin Park H; Yeon Won S; Kim M; Woo Hong S; Kim E; Jin Park S; Taek Lee Y
Eur J Radiol; 2022 May; 150():110239. PubMed ID: 35290908
[TBL] [Abstract][Full Text] [Related]
13. Added Value of Contrast Medium in Whole-Body Hybrid Positron Emission Tomography/Magnetic Resonance Imaging: Comparison between Contrast-Enhanced and Non-Contrast-Enhanced Protocols.
Celebi F; Cindil E; Sarsenov D; Unalan B; Balcı C
Med Princ Pract; 2020; 29(1):54-60. PubMed ID: 31203290
[TBL] [Abstract][Full Text] [Related]
14. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
Schmidt GP; Baur-Melnyk A; Haug A; Utzschneider S; Becker CR; Tiling R; Reiser MF; Hermann KA
Eur Radiol; 2009 Jun; 19(6):1366-78. PubMed ID: 19190917
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.
Wolf MB; Murray F; Kilk K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Eur J Radiol; 2014 Jul; 83(7):1222-1230. PubMed ID: 24793843
[TBL] [Abstract][Full Text] [Related]
16. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.
Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO
Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476
[TBL] [Abstract][Full Text] [Related]
17. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.
Nakanishi K; Kobayashi M; Nakaguchi K; Kyakuno M; Hashimoto N; Onishi H; Maeda N; Nakata S; Kuwabara M; Murakami T; Nakamura H
Magn Reson Med Sci; 2007; 6(3):147-55. PubMed ID: 18037795
[TBL] [Abstract][Full Text] [Related]
18. Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study.
Costelloe CM; Kundra V; Ma J; Chasen BA; Rohren EM; Bassett RL; Madewell JE
J Magn Reson Imaging; 2012 Feb; 35(2):399-408. PubMed ID: 21990095
[TBL] [Abstract][Full Text] [Related]
19. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.
Schmidt GP; Schoenberg SO; Schmid R; Stahl R; Tiling R; Becker CR; Reiser MF; Baur-Melnyk A
Eur Radiol; 2007 Apr; 17(4):939-49. PubMed ID: 16951929
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Schmidt GP; Baur-Melnyk A; Haug A; Heinemann V; Bauerfeind I; Reiser MF; Schoenberg SO
Eur J Radiol; 2008 Jan; 65(1):47-58. PubMed ID: 18082989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
